Close Menu

Twist Bioscience

The hybridization-based test may provide better detection of emerging COVID-19 variants of concern, due to a higher tolerance for probe mismatches than in PCR.

The assay combines Twist's Human Comprehensive Exome with customized content for rare and inherited diseases from Australia-based VCGS.

News items for the in vitro diagnostics industry for the week of Jan. 4, 2021.

The international competition's goal is to spark innovation and accelerate safe returns to work, school, and other public activities.

Industry experts say a receptive market and investor interest in new technologies have spurred the increase in genomics tools and molecular diagnostics IPOs.